BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3343528)

  • 1. Pyrimethamine concentrations in serum and cerebrospinal fluid during treatment of acute Toxoplasma encephalitis in patients with AIDS.
    Weiss LM; Harris C; Berger M; Tanowitz HB; Wittner M
    J Infect Dis; 1988 Mar; 157(3):580-3. PubMed ID: 3343528
    [No Abstract]   [Full Text] [Related]  

  • 2. Sulfadiazine crystalluria revisited. The treatment of Toxoplasma encephalitis in patients with acquired immunodeficiency syndrome.
    Simon DI; Brosius FC; Rothstein DM
    Arch Intern Med; 1990 Nov; 150(11):2379-84. PubMed ID: 2241449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfadiazine-induced crystalluria in AIDS patients with toxoplasma encephalitis.
    Molina JM; Belenfant X; Doco-Lecompte T; Idatte JM; Modai J
    AIDS; 1991 May; 5(5):587-9. PubMed ID: 1863412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxoplasma encephalitis in patients with acquired immune deficiency syndrome: diagnosis and response to therapy.
    Wanke C; Tuazon CU; Kovacs A; Dina T; Davis DO; Barton N; Katz D; Lunde M; Levy C; Conley FK
    Am J Trop Med Hyg; 1987 May; 36(3):509-16. PubMed ID: 3495190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the inhibitory effect on Toxoplasma growth in the serum of AIDS patients during acute therapy for toxoplasmic encephalitis.
    Derouin F; Gérard L; Farinotti R; Maslo C; Leport C
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Sep; 19(1):50-4. PubMed ID: 9732069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral toxoplasmosis in the acquired immune deficiency syndrome.
    Carrazana EJ; Rossitch E; Samuels MA
    Clin Neurol Neurosurg; 1989; 91(4):291-301. PubMed ID: 2555089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxoplasmic encephalitis.
    Luft BJ; Hafner R
    AIDS; 1990 Jun; 4(6):593-5. PubMed ID: 2386623
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term follow-up of patients with AIDS on maintenance therapy for toxoplasmosis.
    Leport C; Tournerie C; Raguin G; Fernandez-Martin J; Niyongabo T; Vildé JL
    Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):191-3. PubMed ID: 2060528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AIDS commentary. Toxoplasmic encephalitis.
    Luft BJ; Remington JS
    J Infect Dis; 1988 Jan; 157(1):1-6. PubMed ID: 3121758
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of acute toxoplasmosis with intravenous clindamycin. The California Collaborative Treatment Group.
    Dannemann BR; McCutchan JA; Israelski DM; Antoniskis D; Leport C; Luft BJ; Chiu J; Vildé JL; Nussbaum JN; Orellana M
    Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):193-5. PubMed ID: 2060529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the efficacy and safety of clindamycin plus pyrimethamine for induction and maintenance therapy of toxoplasmic encephalitis in AIDS.
    Katlama C
    Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):189-91. PubMed ID: 2060527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of pyrimethamine in serum and penetration into brain tissue in humans.
    Leport C; Meulemans A; Robine D; Dameron G; Vildé JL
    AIDS; 1992 Sep; 6(9):1040-1. PubMed ID: 1388895
    [No Abstract]   [Full Text] [Related]  

  • 13. High risk of developing toxoplasmic encephalitis in AIDS patients seropositive to Toxoplasma gondii.
    Zangerle R; Allerberger F; Pohl P; Fritsch P; Dierich MP
    Med Microbiol Immunol; 1991; 180(2):59-66. PubMed ID: 1881367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolution of acute renal failure in toxoplasmic encephalitis despite continuance of sulfadiazine.
    Oster S; Hutchison F; McCabe R
    Rev Infect Dis; 1990; 12(4):618-20. PubMed ID: 2385768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the policy of empiric treatment of suspected Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome.
    Cohn JA; McMeeking A; Cohen W; Jacobs J; Holzman RS
    Am J Med; 1989 May; 86(5):521-7. PubMed ID: 2712059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxoplasmic encephalitis in AIDS.
    Dannemann BR; Remington JS
    Hosp Pract (Off Ed); 1989 Mar; 24(3):139-47, 151-4. PubMed ID: 2493464
    [No Abstract]   [Full Text] [Related]  

  • 17. Toxoplasmic encephalitis in patients with AIDS.
    Israelski DM; Remington JS
    Infect Dis Clin North Am; 1988 Jun; 2(2):429-45. PubMed ID: 3060527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired toxoplasma encephalitis.
    Cottrell AJ
    Arch Dis Child; 1986 Jan; 61(1):84-5. PubMed ID: 3954425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of clindamycin in the treatment of acute toxoplasmosis of the central nervous system.
    Ruf B; Pohle HD
    Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):183-6. PubMed ID: 2060525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine.
    Foppa CU; Bini T; Gregis G; Lazzarin A; Esposito R; Moroni M
    Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):187-9. PubMed ID: 2060526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.